pharmaphorum

NOVEMBER 24, 2021

The pandemic has propelled issues for the pharmaceutical industry to the top of the political and public agenda, from clinical trial recruitment to the journey required for medicines or vaccines to reach patients. The new Life Sciences Vision details priority areas for enhancing regulation. Why is this important for the UK?

Life Science 97

Life Science Regulation Medicine Vaccination 97

pharmaphorum

NOVEMBER 16, 2021

In the second of a two-part series, Leela Barham argues that whilst international comparisons of uptake are useful, there could be more to gain from looking at more medicines and their uptake in England rather than looking at a small set of medicines and their uptake internationally. Consistently focus on innovative medicines.

Medicine 90

Medicine Branding Gene Therapy Life Science 90

Pfizer

SEPTEMBER 27, 2022

We need YOU to design for science! We need YOU to design for science! More of us than ever need science to restore not just the health of our loved ones, but life as we remember it. The  The power of science is the key to unlocking the answers to the world’s most challenging medical questions. Calling All Creatives!

Medicine 52

Medicine Vaccination Vaccine Licensing 52

Pharma in Brief

JUNE 26, 2022

The CTF is part of Canada’s broader Biomanufacturing and Life Sciences Strategy , a $2.2 billion investment which aims to boost Canada’s biomanufacturing and life science sector and ensure Canada’s readiness for future pandemics and health emergencies. The Clinical Trials Fund. Clinical Trials Training Platforms ( CTTP ).

Clinical Trials 52

Clinical Trials Clinical Trials Trial Funding Trials 52

pharmaphorum

MARCH 10, 2022

Driven by advancements in technology, these complex therapeutics have already made waves in life sciences, providing revolutionary treatment options in oncology, immune conditions and rare diseases. Tapping into the momentum of biologics requires investment but identifying the right areas to invest in is a challenge in an evolving market.

Production 98

Production Life Science Development Gene Therapy 98

Pharmaceutical Technology

MAY 8, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Genetics 130

Genetics DNA Genetic Engineering Antibody 130

pharmaphorum

JULY 5, 2022

I recently had the pleasure of attending the PING Conference 2022 , which had the tagline of ‘The Golden Age for Life Sciences Innovation’. Aspirations for the UK in life sciences. Faster access for patients for interventions. Data on all aspects, including stratification of patient types. Reducing complexity across the NHS.

Life Science 98

Life Science Biobanking Medicine Marketing 98

Drug Discovery World

OCTOBER 16, 2023

There is a range of reasons why this area has become focal point for drug discovery, one of which is the fact that it encompasses the University of Oxford and the University of Cambridge, two of the oldest and most prestigious universities in the world. Government investment of £1.3

Drugs 75

Drugs Life Science Gene Therapy Genome 75

Velocity Clinical Research

OCTOBER 25, 2023

Dr. Kris Kowdley received his medical degree from Mount Sinai School of Medicine, completed his residency at Oregon Health Science University and fellowship in gastroenterology and hepatology at Tufts University School of Medicine.

Clinical Trials 64

Clinical Trials Clinical Trials Clinical Research Research 64

The Pharma Data

APRIL 6, 2022

Novartis announced the introduction of a new organizational structure and operating model designed to support the company’s innovation, growth, and productivity ambitions as a focused medicines company in the coming decade. Victor Bulto, currently Head of US Pharmaceuticals, will become President, Innovative Medicines US.

Medicine 52

Medicine Sales Development Marketing 52

pharmaphorum

APRIL 1, 2022

With the new Health and Care Bill edging ever closer to receiving Royal Assent, life sciences companies in the UK are preparing to navigate the most significant piece of NHS legislation in a decade. He is also Chair of the European Medicines Group. Jim McArdle , commercial director, Interface Clinical Services, IQVIA.

Marketing 98

Marketing Life Science Pharmacy Sales 98

Drug Discovery World

OCTOBER 18, 2022

Dr Stephan Emmerth and Paul Eschmann, Basel Area Business & Innovation, explain the benefits of being based in Basel – the talent pool, global players, academic institutions and investors, for example. . An international business hub. and startups to multinational corporations – covering a range of industries. .

Life Science 52

Life Science Engineer Research Clinical Trials 52

pharmaphorum

APRIL 5, 2022

This was the subject of a recent pharmaphorum webinar, sponsored by Healthware International, where Healthware CEO Roberto Ascione and Politecnico di Milano Professor Emanuele Lettieri laid out plans for a new executive education programme in digital health innovation. ” The need for a new programme. .

Life Science 122

Life Science Development Research Medicine 122

Drug Discovery World

JUNE 15, 2023

The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared mission to drive the translation of all cell and gene (CGT) therapies for the benefit of patients worldwide. DDW’s Megan Thomas heard from attendees about key trends in the sector.

Regulation 52

Regulation Production Development Medicine 52

The Pharma Data

MARCH 28, 2022

Gilead Sciences, Inc., Gilead Sciences, Inc., The funding recipients will focus on advancing at least one of three focus areas: Comprehensive HIV Innovation, Digital Health Innovation and Community Outreach and Education.

Medicine 52

Medicine Manufacturing Research 52

Drug Discovery World

MARCH 13, 2024

With government support and strong academic institutions, does Singapore have what it takes to become a global centre for life sciences? DDW’s Diana Spencer explores how the country is turning pioneering science into a successful biotech industry. UK-based molecular diagnostics group Yourgene operates in Singapore.

Life Science 69

Life Science Genome Genomics Research 69

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Data privacy and protection, patient voice.

Genome 104

Genome Genomics Research Medicine 104

Drug Discovery World

AUGUST 3, 2023

In the first part of this series of articles focused on plant-based medicines, DDW’s Megan Thomas evaluates the use of medical cannabis in drug discovery. Medical cannabis is often a first-thought when regarding plant-based medicines, but there remains public scepticism, arguably due to the regulations relating to the substance.

Medicine 52

Medicine Scientist Production Regulation 52

XTalks

MARCH 20, 2024

As I became adept at integrations and operating models, my focus shifted to relationship and alliance management. My career has been a progression of roles, continually expanding in scope and leadership, culminating in a focus on operational excellence. Can you begin by telling us about your experience in clinical research?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

MAY 18, 2022

One research-driven company with a strong patient focus in neurology is UCB. “In says Charl van Zyl, UCB’s executive vice president neurology & head of Europe & International Markets. Beyond epilepsy, there are two next areas of focus and rapid development: neuroinflammation and neurodegeneration.

Gene Therapy 81

Gene Therapy Gene Genetics Development 81

pharmaphorum

AUGUST 17, 2022

The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. The life sciences ecosystem. There’s no effort to present any weighting for the indicators and stakeholders are likely to focus on those that matter most to them. Interest in indicators.

Life Science 57

Life Science Medicine Marketing Regulation 57

Drug Discovery World

APRIL 29, 2024

The recent interest in cannabinoids as potential sources for medicinal use has been a long time coming. Advances in brain science and modern chemistry are supporting a new generation of investigation into cannabinoids, the active compounds in the cannabis plant. Ann Intern Med. The risk of addiction is a serious one.

Research 59

Research Drugs Production Development 59

ACRP blog

APRIL 30, 2024

This requires us to focus less on the staff’s years of experience and more on their skills. Wolfe explains that “we recently expanded this to a rotational program offering experience within multiple areas and departments, giving a broader understanding of our industry and processes.

Clinical Research 59

Clinical Research Clinical Trials Clinical Trials Clinical Research Coordinator 59

ACRP blog

JUNE 7, 2023

Undoubtedly, the expectations for precision medicine are high,” Olsen adds. Many believe that in addition to improving individual patient outcomes, precision medicine holds promise to reduce overall treatment costs by eliminating ineffective or unnecessary medical care and by identifying high-risk patients who need early targeted care.

Big Data 59

Big Data Clinical Research Research Clinical Trials 59

pharmaphorum

DECEMBER 15, 2021

It has been the focus of much of my career as a physician inside the drug industry. Often, patient-advocacy teams are inadequately funded and staffed both to manage external relationships and pull off comprehensive internal education simultaneously. Let me make clear that patient engagement is essential in its own right.

Pharma Companies 144

Pharma Companies Development Medicine Clinical Trials 144

Rethinking Clinical Trials

AUGUST 28, 2023

 Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. The new structure aims to provide clarity and better readability.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

AUGUST 28, 2023

 Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. The new structure aims to provide clarity and better readability.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Pharmaceutical Technology

DECEMBER 22, 2022

Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community. Blueprint Medicines wins the Financing award this year after securing significant financing partnerships worth up to $1.25bn.

Insulin 130

Insulin Production Development Genetics 130

pharmaphorum

MARCH 8, 2022

How did you get into life sciences? After a few years, I decided I wanted to move into the commercial side of the business, so I completed an MBA and went on to hold various positions in Corporate Business Development, Life Science and Healthcare. I also had to learn to navigate internal politics, which I was not used to.

Life Science 98

Life Science Engineer Scientist Doctors 98

The Pharma Data

NOVEMBER 16, 2020

These goals span Regeneron’s three responsibility priority areas, focusing on the environmental and social topics that matter most to our stakeholders and business. ” About Regeneron Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases.

Medicine 52

Medicine FDA Approval Engineer Antibody 52

Drug Discovery World

MARCH 16, 2023

International Journal of Molecular Science, 21(4): 1537. The designation is an important milestone in the development of EP0042, and underscores the work we are already undertaking towards accelerating its potential access to patients. and Leung, A. Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML.

Drugs 52

Drugs FDA Approval Development Research 52

Drug Discovery World

FEBRUARY 10, 2023

Though not without its challenges, the life sciences industry in Scandinavia is well represented and acts as a serious contender for R&D output. More so, the Karolinska Institute is ranked at number seven in the world for the subjects of life sciences and medicine.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

The Pharma Data

MAY 5, 2022

Using donations, partnerships and collective action, Foundation S will focus on three critical areas: childhood cancer, the health of communities most vulnerable to the effects of climate change and pollution, and access to lifesaving medicines and vaccines. ” Foundation S will operate as a “think & do tank.”

Vaccination 52

Vaccination Vaccine Medicine Development 52

XTalks

DECEMBER 11, 2023

stands as a thriving medical device company in the commercial stage, with a dedicated focus on creating transformative solutions for individuals grappling with venous diseases. This personalized suspension is then delicately sprayed onto the designated treatment areas, facilitating the healing process. Its CAGR is 244 percent.

Production 110

Production Sales In-Vitro Development 110

Drug Discovery World

OCTOBER 20, 2022

Japan continues to be one of the largest pharmaceutical markets in the world, despite what the International Trade Administration described as ‘a challenging business landscape due to demographics’ 1. According to the International Trade Administration’s market overview, anti-tumour agents brought in the largest sales in 2020 in Japan.

Development 52

Development Drugs Life Science Marketing 52

Drug Discovery World

NOVEMBER 24, 2023

However, as we see every day, modern medicine has both incremental and major improvements, showing that the best innovations and most transformative outcomes can come from extreme pressures. But ultimately, for medicines to be rolled out worldwide, they need to work with not against the market.

Research 59

Research Life Science Gene Editing Vaccination 59

pharmaphorum

AUGUST 5, 2021

Medicines Discovery Catapult (MDC) today announces the relaunch of radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) in Manchester. It also creates an opportunity for theranostics – an area of potentially significant impact – to flourish within the UK. ” Find out more about MDCs PET Imaging expertise here.

Medicine 52

Medicine In-Vivo Packaging Packaging 52